Table 1 Demographic characteristics
Characteristic | All patients (n = 37) | Methohexital only (n = 13) | Etomidate only (n = 8) | Methohexital and etomidate (n = 16) |
|---|---|---|---|---|
Age (year), mean (sd) | 52.3 (13.7) | 53.5 (16.6) | 47.4 (16.5) | 53.9 (9.3) |
Gender, n (%) | ||||
Male | 9 (24) | 3 (23) | 0 (0) | 6 (38) |
Female | 28 (76) | 10 (77) | 8 (100) | 10 (63) |
Weight (kg), mean (sd) | 77.8 (16.2) | 71.7 (9.9) | 86.2 (21.9) | 78.5 (16.1) |
Diagnosis, n (%) | ||||
Affective disorder | 30 (81) | 12 (92) | 7 (88) | 11 (69) |
Schizophrenia | 3 (8) | 1 (8) | 0 (0) | 2 (12) |
Unclear | 4 (11) | 0 (0) | 1(12) | 3 (19) |
Comorbidity, n (%) | ||||
CVA/TIA | 1 (3) | 1 (8) | 0 (0) | 0 (0) |
Epilepsy | 2 (6) | 0 (0) | 1 (13) | 1 (7) |
Renal impairment (GFR < 60) | 4 (11) | 1 (8) | 2 (25) | 1 (7) |
Medication use, n (%) | ||||
Antihypertensive drugs | 11 (31) | 4 (31) | 3 (38) | 4 (27) |
Antipsychotic drugs | 25 (71) | 9 (69) | 5 (63) | 11 (79) |
Benzodiazepine | 28 (80) | 11 (85) | 7 (88) | 10 (71) |
Tricyclic antidepressant | 11 (31) | 4 (31) | 2 (25) | 5 (36) |
Opioids | 0 (0) | 0 (0) | 0 (0) | 0 (0) |